Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px
Organisation › Details

ERS Genomics Ltd.

ERS Genomics was formed to commercialise the foundational CRISPR-Cas9 intellectual property held by Dr. Emmanuelle Charpentier. Licenses are available for research and sale of products and services across multiple fields including: research tools, kits, reagents; discovery of novel targets for therapeutic intervention; cell lines for discovery and screening of novel drug candidates; GMP production of healthcare products; production of industrial materials such as enzymes, biofuels and chemicals; and synthetic biology. *

 

Period Start 2014-02-17 established
Products Industry CRISPR gene editing technology
  Industry 2 IP services
Person Person Rhodes, Eric (ERS Genomics 201606–202405 CEO before Horizon Discovery + Sigma-Aldrich + Sangamo Biosciences)
     
Region Region Dublin
  Country Ireland, Republic of
  Street 88 Harcourt Street
  City Dublin 2
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: 
     
   
Record changed: 2024-09-04

Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x200px

More documents for ERS Genomics Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x300px




» top